PepGNP-ChikV

N/A

Report date: 2026/02/09 20:01:27

Base Information

Drug NamePepGNP-ChikV
Drug Alias NameSynthetic Nanoparticle-based T Cell Next-generational Vaccine (Gylden Pharma)PepGNP-ChikV
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsChikungunya Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGylden Pharma Ltd
Inactive CompaniesN/A
Active IndicationsChikungunya Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A